Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial

Christer Allgulander, Torben Jørgensen, Alan Wade, C. François, Nicolas Despiégel, Pascal Auquier, M Toumi

Current Medical Research and Opinion · 2007 · 28 citations · 22 references

Abstract

GAD adversely affects patient functioning and daily life. Short-term treatment with escitalopram reverses this impairment to population norms. GAD relapse is associated with a deterioration of HRQoL and work productivity.

References

22